Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus
2007
A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
2009
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
2014
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
2010
Exercise training increases size of hippocampus and improves memory
2011 Standout
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
2019
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
2013
IDH1andIDH2Mutations in Gliomas
2009 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Epigenetic regulation of aging stem cells
2011
Applications and limitations of radiomics
2016
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours
2007
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging
2003
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Regulation of tumor pH and the role of carbonic anhydrase 9
2007
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature
2012
Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma
2012
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma
2012
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
A 31-Year-Old Woman With a Transformed Low-grade Glioma
2010
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
2011
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
2008
Anatomic, Physiologic and Metabolic Imaging in Neuro-Oncology
2008
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
Immunotoxin therapy of cancer
2006
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Mimicking white matter tract topography using core–shell electrospun nanofibers to examine migration of malignant brain tumors
2013
Incidental Findings on Brain MRI in the General Population
2007 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Clinical and radiographic features of peritumoral infarction following resection of glioblastoma
2006
Radiomics: the process and the challenges
2012 Standout
Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
2011
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
Advanced MRI of Adult Brain Tumors
2007
Quantitative imaging biomarkers in neuro-oncology
2009
A comprehensive outlook on intracerebral therapy of malignant gliomas
2010
Malignant Gliomas in Adults
2008 Standout
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
2013
Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features
2014
Glioma Stem Cells: A Midterm Exam
2008
DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMAS
2009
Gastric cancer
2020 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma
2016
Primary brain tumours in adults
2012 Standout
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
2008
Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
2015
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype
2013
Imaging of angiogenesis: from microscope to clinic
2003
The Hallmarks of Aging
2013 Standout
Non–Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data—Methods and Preliminary Results
2012
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Non-Stem Cell Origin for Oligodendroglioma
2010
Brain Tumor Imaging in Clinical Trials
2008
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
2009
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
2010 Standout
Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?
2015
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Analysis of perfusion weighted image of CNS lymphoma
2009
Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging
2009
Radiologically Defined Ecological Dynamics and Clinical Outcomes in Glioblastoma Multiforme: Preliminary Results
2014
The cancer genome
2009 StandoutNature
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Ethical and practical considerations in managing incidental findings in functional magnetic resonance imaging
2002
Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated Cetuximab
2007
Antibody-Mediated Encephalitis
2018 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Diagnosis and Treatment of Recurrent High-Grade Astrocytoma
2006
Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
2007
Quantitative Imaging in Cancer Evolution and Ecology
2013
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
2009
Hyperpolarized [1-13C] Glutamate: A Metabolic Imaging Biomarker of IDH1 Mutational Status in Glioma
2014
The Potential of Radiomic-Based Phenotyping in Precision Medicine
2016
Molecular Targeting and Treatment of EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibody L8A4
2006
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model
2004
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Development and Evaluation of an Open-Source Software Package “CGITA” for Quantifying Tumor Heterogeneity with Molecular Images
2014
Advances in magnetic resonance imaging of brain tumours
2003
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
2009
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Advances in magnetic resonance imaging of brain tumours.
2003
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics
2018 StandoutNobel
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
2005
Insular glioma resection: assessment of patient morbidity, survival, and tumor progression
2009
An extent of resection threshold for newly diagnosed glioblastomas
2011 Standout
Works of Soonmee Cha being referenced
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
2008
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging
2003
Imaging Glioblastoma Multiforme
2003
Dynamic susceptibility contrast perfusion imaging of radiation effects in normal‐appearing brain tissue: Changes in the first‐pass and recirculation phases
2005
Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13—PE38QQR for recurrent malignant glioma
2005
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
2009
Adult‐onset drug‐refractory seizure disorder associated with anti–voltage‐gated potassium‐channel antibody
2009
Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
1999
Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology
2003
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury
2005
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
2012
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme
2010
Measuring blood volume and vascular transfer constant from dynamic, T‐weighted contrast‐enhanced MRI
2004
High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging
2002
Update on brain tumor imaging
2005
Glioblastoma Multiforme Regional Genetic and Cellular Expression Patterns: Influence on Anatomic and Physiologic MR Imaging
2010
Relative Cerebral Blood Volume Measurements in Intracranial Mass Lesions: Interobserver and Intraobserver Reproducibility Study
2002
Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
2009
Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype
2007
CNS Tumors
2006
Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas
2009
Perfusion MR Imaging of Brain Tumors
2004
Relationship between choline and apparent diffusion coefficient in patients with gliomas
2008
Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas
2018
Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging
2002
Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
2001
Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.
2003
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.
2005
Magnetic Resonance of 2-Hydroxyglutarate in IDH1 -Mutated Low-Grade Gliomas
2012
Relative recirculation: what does it mean?
2002
Update on brain tumor imaging: from anatomy to physiology.
2006
Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.
2005
Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity.
2005
Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.
2006
Proton MR spectroscopy of tumefactive demyelinating lesions.
2002
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.
2003